Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
Dr. Derek O’Hagan GSK Vaccine Research, USA2 Talks
Dr Derek O'Hagan is the Global Head of Vaccine Chemistry and Formulation for GSK vaccines Research in Cambridge, MA. He is a former academic researcher from the UK and a qualified pharmacist and has spent the last 20 years working on vaccine delivery and formulation in the industry in the... read moreUS. He has undertaken basic research on several concepts that have moved into clinical testing and has also worked on products that are currently licensed for human use, including several adjuvanted vaccines.